Table 1.
Ref. | No. of patients’ | Pathologic T1 or T2 | Lymph node involvement | Distant metastasis | Survival | |
Cases | Age (yr) | |||||
Kulkarni et al[14] | 933 | 60 (median) | Not reported | 5.1% | Not reported | 88% (5 yr) |
Coates et al[15] | 376 | 62 (mean) | 90% | 6.1% | 1.1% (site not specified) | 90% (10 yr) |
Ghabach et al[11] | 338 | 63 (mean) | 95% | 1.7% | < 1% (site not specified) | 94.9% (10 yr) |
Thompson et al[16] | 244 | 62 (median) | 92% | 4.9% | 2.9% (site not specified) | 94.9% (10 yr) |
Khanfir et al[17] | 61 | 59 (median) | 88% | 0% | 6.5% (bone, liver, lung) | 94% (5 yr) |
Defaud-Hénon et al[18] | 30 | 61 (median) | 95% | 0% | 10% (bone, liver, lung) | Not calculated |
Vranic et al[19] | 21 | 60.8 (mean) | 85% | 0% | 20% (bone, kidney, lung) | 90% (5 yr) |